National Robotics-Assisted Radical Prostatectomy Database

Recruiting now

Conditions studied: Database, Prostate Cancer, Robotic-assisted Radical Prostatectomy, Surgical Outcomes, Oncological Outcomes, Patient Reported Outcome Measures, Learning Curve

In brief

In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients. Studies conducted so far are small scale studies and the results from these studies cannot be generalized to the population at large in Australia. So, there is need for a largescale study that will look at the long-term outcomes and the factors that impact robotic surgeries across the metropolitan and rural hospital sectors. Hence, this comprehensive database has been setup to collaborate with major hospitals, across metropolitan and rural areas in Australia. Through this database, researchers will be able to explore the diagnostic pathway for Prostate cancer and understand the long-term benefits of robotic surgery through patient reported questionnaires. Outcomes from this database will also help compare the quality of care against other powerhouses of robotic surgery. Eventually, the database aims to standardize diagnostic pathways and clinical notes that are the same across different hospitals conducting robotic-assisted surgeries for Prostatectomy and improve care for prostate cancer patients across the country.

Key facts

Study ID

NCT06279260

Run by

Melbourne Health

People needed

10000

Starts

2024-07-01

Expected to finish

2050-12-01

Last updated by the study team

2024-08-26

Who can join

Age: 18 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• To be eligible to participate in this database, an individual must meet all of the following criteria:
• Individuals who consent to participate,
• within the age range of 18 to 90 years,
• confirmed diagnosis of localized prostate cancer (PCa)
• patients receiving medical attention at hospitals engaged in collaborative efforts with the designated database.

You may not qualify if…

• Participants are not eligible to take part in the database:
• Individuals who have not undergone robotic surgery for prostatectomy or TP biopsy. ,
• without a diagnosis of prostate cancer or
• who decline to provide consent for the collection of their health information
• Under the age of 18 years.

Where it is running

• Royal Melbourne Hospital — Melbourne, Victoria, Australia (enrolling)
• Barwon health — Geelong, Victoria, Australia
• Austin Healthcare — Melbourne, Victoria, Australia
• E.J Whitten Prostate Cancer Centre, Epworth Healthcare — Melbourne, Victoria, Australia
• Ballarat Health — Ballarat, Victoria, Australia
• Western Heath — Melbourne, Victoria, Australia
• Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia
• St. Vincent's Private Hospital — Melbourne, Victoria, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.